Literature DB >> 5704527

Effects of oral cysteine, penicillamine and N-acetyl-penicillamine on adjuvant arthritis in rats.

B Klamer, E T Kimura, M Makstenieks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5704527     DOI: 10.1159/000135976

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


× No keyword cloud information.
  8 in total

1.  The antiinflammatory action of some compounds with antioxidant properties.

Authors:  L Levy
Journal:  Inflammation       Date:  1976-12       Impact factor: 4.092

2.  Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.

Authors:  T Matsubara; R Saura; K Hirohata; M Ziff
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

3.  Failure of oral D-penicillamine to modify adjuvant arthritis or immune response in the rat.

Authors:  S P Liyanage; H L Currey
Journal:  Ann Rheum Dis       Date:  1972-11       Impact factor: 19.103

4.  Prolonged treatment with D-penicillamine: effects on adjuvant arthritis in the rat.

Authors:  C J Dunn; M Prouteau; M Delahaye; T Purcell; D Branceni
Journal:  Agents Actions       Date:  1984-02

5.  Investigations on the influence of cyclophosphamide, gold sodium thiomalate and D-penicillamine on nystatin oedema and adjuvant arthritis.

Authors:  E Arrigoni-Martelld; E Bramm
Journal:  Agents Actions       Date:  1975-08

6.  Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4.

Authors:  P E Lipsky; M Ziff
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

7.  Studies of D-penicillamine on strain variability and lymph node cellularity in adjuvant arthritis.

Authors:  S Nakaike; K Takeshita; M Shiono; N Tomita; S Otomo; H Aihara
Journal:  Agents Actions       Date:  1985-09

8.  Historical perspectives on penicillamine.

Authors:  L Fernandes; H Berry; E Hamilton
Journal:  J R Coll Physicians Lond       Date:  1980-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.